Breast cancer cells, once nested to bone, undergo partial osteomimicry by acquisition of typical bone cell markers including ICAM-1, CDH11, OPN, osteonectin (SPARC), osteocalcin (BGLAP) and cellular communication network factor 3 (CCN3). This evidence concerns the gene CCN3 and breast carcinoma.